Article
Directing LRRK2 to membranes of the endolysosomal pathway triggers RAB phosphorylation and JIP4 recruitment.
Neurobiology of disease - 1 Aug 2022
Kluss Jillian H, Bonet-Ponce Luis, Lewis Patrick A, Cookson Mark R
Abstract excerpt
Coding mutations in the Leucine-rich repeat kinase 2 (LRRK2) gene, which are associated with dominantly inherited Parkinson's disease (PD), lead to an increased activity of the encoded LRRK2 protein kinase. As such, kinase inhibitors are being considered as therapeutic agents for PD. It is therefore of interest to understand the mechanism(s) by which LRRK2 is activated during cellular signaling. Lysosomal...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
